MTR offers you extensive bio-analytical services in drug development by conducting analysis ranging from evaluation of drugs in Preclinical samples to that in Human trials. We have put together a team with strong scientific knowledge combined with the latest automated equipment to meet the needs of our clients. Our laboratories are GLP certified.

     Our ability to undertake studies for special population & unconventional molecules sets us apart fromthe competition. The bio-analytical department with entry/exit access controls has a carpet area of approximately 2000 Sq. ft

     MTR’s expertise in performing BA/BE studies is based on several years of scientific study conduct. Our dedicated study project teams are guided by significant clinical experience for various study types and therapeutic areas. Our clinics offer a complete set of bioequivalence services from our experienced physicians and support staff. Staffing for every sponsor program includes a dedicated project manager, rigorous quality control and quality assurance to ensure data integrity and timely report delivery.

     MTR is your partner with flexible Phase I / Bioequivalence resources at our two clinical locations in Chennai and one location in coimbatore, India. In addition to having common SOPs for each of our clinics, initial and ongoing training modules universally support each of our clinical operations.

     MTR provides full range of BA/BE services - Study design, protocol preparation, Ethics committee review submissions, selection of subjects, IP import, Sample export, pharmacokinetic and statistical data evaluations, study result report preparations and archival of study data documents.

Dosage forms - tablets, capsules, suspension, suppository, topical Immediate and modified release formulations Trans dermal patches ­­­	Studies in special populations
Light-sensitive compounds Food effect studies, apple sauce studies Multiple dose steady state studies	Studies in cancer patients Dose escalation studies Repeat ‘first-in-man’ studies Clinical end point studies